Amgen

Following Follow

- Thousand Oaks,California, United States
Website
www.amgen.com
About Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.

Followers (17)

presentations (10)

Q1 2012 Amgen Earnings Confer... from Amgen 1 month ago, 398 views
Q4 2011 Amgen Earnings Confer... from Amgen 4 months ago, 412 views
Q3 2011 amgen earnings confer... from Amgen 7 months ago, 587 views
Q2 2011 Amgen Earnings Confer... from Amgen 10 months ago, 721 views

documents

Amgen 2011 Annual Report and ... from Amgen 1 month ago, 236 views
2010 Environmental Sustainabi... from Amgen 1 year ago, 882 views
Introduction to Biotechnology from Amgen 1 year ago, 735 views
Amgen 2010 Annual Report and ... from Amgen 1 year ago, 944 views

This site and information is intended for investors, members of the financial community and the media. These materials may contain forward-looking statements, which involve significant risks and uncertainties that could cause actual results to differ materially from those described. Except where otherwise indicated, Amgen is providing this information as of the date the materials are posted to this site and does not undertake any obligation to update any forward-looking statements contained in these materials as a result of new information, future events or otherwise. If you are an investor or member of the financial community and have any questions, please call Amgen Investor Relations at 805-447-1060. If you are a member of the media and have any questions, please visit our media contacts page on Amgen.com.